Search

Your search keyword '"Powers, Eric"' showing total 424 results

Search Constraints

Start Over You searched for: Author "Powers, Eric" Remove constraint Author: "Powers, Eric"
424 results on '"Powers, Eric"'

Search Results

1. Coherent Exciton-Lattice Dynamics in a 2D Metal Organochalcogenolate Semiconductor

2. Persistent Enhancement of Exciton Diffusivity in CsPbBr3 Nanocrystal Solids

4. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program

5. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques

7. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

11. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study

13. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

16. Comparison of Lipid Deposition at Coronary Bifurcations Versus at Nonbifurcation Portions of Coronary Arteries as Determined by Near-Infrared Spectroscopy

20. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial

21. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation

36. Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study.

37. Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study

40. SLIPPAGE AND THE CHOICE OF MARKET OR LIMIT ORDERS IN FUTURES TRADING

41. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

46. Management turnover in subsidiaries of conglomerates versus stand-alone firms

49. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

Catalog

Books, media, physical & digital resources